Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 359

1.

"If I ever did have a daughter, I wouldn't raise her in New Brunswick:" exploring women's experiences obtaining abortion care before and after policy reform.

Foster AM, LaRoche KJ, El-Haddad J, DeGroot L, El-Mowafi IM.

Contraception. 2017 May;95(5):477-484. doi: 10.1016/j.contraception.2017.02.016. Epub 2017 Feb 21.

PMID:
28232129
2.

Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients.

Giovannoni G, Cohen JA, Coles AJ, Hartung HP, Havrdova E, Selmaj KW, Margolin DH, Lake SL, Kaup SM, Panzara MA, Compston DA; CARE-MS II Investigators.

Neurology. 2016 Nov 8;87(19):1985-1992. Epub 2016 Oct 12.

3.

The Non-Thyroidal Illness Syndrome.

DeGroot LJ.

In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.
2015 Feb 1.

4.

Graves’ Disease and the Manifestations of Thyrotoxicosis.

DeGroot LJ.

In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.
2015 Jul 11.

5.

Thyroid Cancer.

Pacini F, DeGroot LJ.

In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.
2013 Mar 27.

6.

Hashimoto’s Thyroiditis.

Akamizu T, Amino N, DeGroot LJ.

In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.
2013 Dec 20.

7.

Autoimmunity to the Thyroid Gland.

Weetman A, DeGroot LJ.

In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.
2016 Jan 14.

8.

Diagnosis and Treatment of Graves’ Disease.

DeGroot LJ.

In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.
2016 Nov 2.

9.

A study of recurrence and death from papillary thyroid cancer with 27 years of median follow-up.

Grogan RH, Kaplan SP, Cao H, Weiss RE, Degroot LJ, Simon CA, Embia OM, Angelos P, Kaplan EL, Schechter RB.

Surgery. 2013 Dec;154(6):1436-46; discussion 1446-7. doi: 10.1016/j.surg.2013.07.008. Epub 2013 Sep 26.

PMID:
24075674
10.

Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial.

Cohen JA, Coles AJ, Arnold DL, Confavreux C, Fox EJ, Hartung HP, Havrdova E, Selmaj KW, Weiner HL, Fisher E, Brinar VV, Giovannoni G, Stojanovic M, Ertik BI, Lake SL, Margolin DH, Panzara MA, Compston DA; CARE-MS I investigators.

Lancet. 2012 Nov 24;380(9856):1819-28. doi: 10.1016/S0140-6736(12)61769-3. Epub 2012 Nov 1.

PMID:
23122652
11.

Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial.

Coles AJ, Twyman CL, Arnold DL, Cohen JA, Confavreux C, Fox EJ, Hartung HP, Havrdova E, Selmaj KW, Weiner HL, Miller T, Fisher E, Sandbrink R, Lake SL, Margolin DH, Oyuela P, Panzara MA, Compston DA; CARE-MS II investigators.

Lancet. 2012 Nov 24;380(9856):1829-39. doi: 10.1016/S0140-6736(12)61768-1. Epub 2012 Nov 1.

PMID:
23122650
12.

Alemtuzumab vs. interferon beta-1a in early multiple sclerosis.

CAMMS223 Trial Investigators, Coles AJ, Compston DA, Selmaj KW, Lake SL, Moran S, Margolin DH, Norris K, Tandon PK.

N Engl J Med. 2008 Oct 23;359(17):1786-801. doi: 10.1056/NEJMoa0802670.

13.

Familial variation in episode frequency in bipolar affective disorder.

Fisfalen ME, Schulze TG, DePaulo JR Jr, DeGroot LJ, Badner JA, McMahon FJ.

Am J Psychiatry. 2005 Jul;162(7):1266-72.

PMID:
15994708
14.

Viral mediated gene therapy for the management of metastatic thyroid carcinoma.

DeGroot LJ, Zhang R.

Curr Drug Targets Immune Endocr Metabol Disord. 2004 Sep;4(3):235-44. Review.

PMID:
15379725
15.
16.

CTLA-4 AT-repeat polymorphism reduces the inhibitory function of CTLA-4 in Graves' disease.

Takara M, Kouki T, DeGroot LJ.

Thyroid. 2003 Dec;13(12):1083-9.

PMID:
14751028
17.
18.

Tumor-specific gene therapy for undifferentiated thyroid carcinoma utilizing the telomerase reverse transcriptase promoter.

Takeda T, Inaba H, Yamazaki M, Kyo S, Miyamoto T, Suzuki S, Ehara T, Kakizawa T, Hara M, DeGroot LJ, Hashizume K.

J Clin Endocrinol Metab. 2003 Aug;88(8):3531-8.

PMID:
12915632
19.

Multiple fragments of human TG are capable of inducing oral tolerance to whole human TG.

Gardine CA, Gentile F, Pellegrini C, Giallauria F, Torelli G, Kouki T, DeGroot L.

J Endocrinol Invest. 2003 Apr;26(4):294-300.

PMID:
12841535
20.

Supplemental Content

Loading ...
Support Center